$BIOC Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIOCEPT INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in BIOCEPT INC. Get notifications about new insider transactions in BIOCEPT INC for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 22 2020 | BIOC | BIOCEPT INC | Riccitelli Samuel D | Director | Option Exercise | A | 4.63 | 10,000 | 46,300 | 10,000 | |
| Oct 22 2020 | BIOC | BIOCEPT INC | Riccitelli Samuel D | Director | Option Exercise | A | 4.63 | 10,000 | 46,300 | 10,000 | |
| Oct 05 2020 | BIOC | BIOCEPT INC | TERRY MICHAEL J | Sr VP Comm. Operati ... | Option Exercise | A | 4.50 | 48,300 | 217,350 | 48,300 | |
| Oct 05 2020 | BIOC | BIOCEPT INC | Kennedy Timothy | CFO, Sr V.P. Operat ... | Option Exercise | A | 4.50 | 138,000 | 621,000 | 138,000 | |
| Oct 05 2020 | BIOC | BIOCEPT INC | DUGAN MICHAEL C | Chief Med Off & Med ... | Option Exercise | A | 4.50 | 69,000 | 310,500 | 69,000 | |
| Oct 05 2020 | BIOC | BIOCEPT INC | Nall Michael W. | CEO & President | Option Exercise | A | 4.50 | 241,500 | 1,086,750 | 241,500 | |
| Sep 01 2020 | BIOC | BIOCEPT INC | DUGAN MICHAEL C | Chief Med Off & Med ... | Option Exercise | A | 0.67 | 54,900 | 36,509 | 54,900 | |
| Sep 01 2020 | BIOC | BIOCEPT INC | DUGAN MICHAEL C | Chief Med Off & Med ... | Option Exercise | A | 0.67 | 54,900 | 36,509 | 54,900 | |
| Jun 12 2020 | BIOC | BIOCEPT INC | HALE DAVID F | Director | Sell | S | 0.56 | 556 | 309 | 867 | 1.4 K to 867 (-39.07 %) |
| Jun 12 2020 | BIOC | BIOCEPT INC | HALE DAVID F | Director | Sell | S | 0.56 | 556 | 309 | 867 | 1.4 K to 867 (-39.07 %) |
| Jun 12 2020 | BIOC | BIOCEPT INC | HALE DAVID F | Director | Sell | S | 0.55 | 445 | 247 | 112 | 557 to 112 (-79.89 %) |
| Jun 12 2020 | BIOC | BIOCEPT INC | HALE DAVID F | Director | Sell | S | 0.55 | 445 | 247 | 112 | 557 to 112 (-79.89 %) |
| Jun 12 2020 | BIOC | BIOCEPT INC | HALE DAVID F | Director | Sell | S | 0.56 | 159 | 89 | 3,477 | 3.6 K to 3.5 K (-4.37 %) |
| Jun 12 2020 | BIOC | BIOCEPT INC | HALE DAVID F | Director | Sell | S | 0.56 | 159 | 89 | 3,477 | 3.6 K to 3.5 K (-4.37 %) |
| Jun 09 2020 | BIOC | BIOCEPT INC | Wilson Margaret Faye | Director | Option Exercise | A | 0.48 | 500 | 240 | 500 | |
| Jun 09 2020 | BIOC | BIOCEPT INC | Wilson Margaret Faye | Director | Option Exercise | A | 0.48 | 500 | 240 | 500 | |
| Jun 09 2020 | BIOC | BIOCEPT INC | Chandler Marsha Alpert | Director | Option Exercise | A | 0.48 | 500 | 240 | 500 | |
| Jun 09 2020 | BIOC | BIOCEPT INC | Gerhardt Bruce | Director | Option Exercise | A | 0.48 | 500 | 240 | 500 | |
| Jun 09 2020 | BIOC | BIOCEPT INC | HALE DAVID F | Director | Option Exercise | A | 0.48 | 500 | 240 | 500 | |
| Jun 09 2020 | BIOC | BIOCEPT INC | ROYSTON IVOR | Director | Option Exercise | A | 0.48 | 500 | 240 | 500 | |
| Jun 09 2020 | BIOC | BIOCEPT INC | HUEBNER BRUCE A | Director | Option Exercise | A | 0.48 | 500 | 240 | 500 | |
| Jun 19 2019 | BIOC | BIOCEPT INC | Nall Michael W. | CEO & President | Option Exercise | A | 0.91 | 675,000 | 614,250 | 675,000 | |
| Jun 19 2019 | BIOC | BIOCEPT INC | HALE DAVID F | Director | Option Exercise | A | 1.02 | 500 | 510 | 500 | |
| Jun 19 2019 | BIOC | BIOCEPT INC | HALE DAVID F | Director | Option Exercise | A | 0.91 | 30,000 | 27,300 | 30,000 | |
| Jun 19 2019 | BIOC | BIOCEPT INC | ROYSTON IVOR | Director | Option Exercise | A | 1.02 | 500 | 510 | 500 | |
| Jun 19 2019 | BIOC | BIOCEPT INC | ROYSTON IVOR | Director | Option Exercise | A | 0.91 | 30,000 | 27,300 | 30,000 | |
| Jun 19 2019 | BIOC | BIOCEPT INC | Wilson Margaret Faye | Director | Option Exercise | A | 1.02 | 500 | 510 | 500 | |
| Jun 19 2019 | BIOC | BIOCEPT INC | Wilson Margaret Faye | Director | Option Exercise | A | 0.91 | 30,000 | 27,300 | 30,000 | |
| Jun 19 2019 | BIOC | BIOCEPT INC | Gerhardt Bruce | Director | Option Exercise | A | 1.02 | 500 | 510 | 500 | |
| Jun 19 2019 | BIOC | BIOCEPT INC | Gerhardt Bruce | Director | Option Exercise | A | 0.91 | 30,000 | 27,300 | 30,000 | |
| Jun 19 2019 | BIOC | BIOCEPT INC | Kennedy Timothy | CFO, Sr V.P. Operat ... | Option Exercise | A | 0.91 | 400,000 | 364,000 | 400,000 | |
| Jun 19 2019 | BIOC | BIOCEPT INC | HUEBNER BRUCE A | Director | Option Exercise | A | 1.02 | 500 | 510 | 500 | |
| Jun 19 2019 | BIOC | BIOCEPT INC | HUEBNER BRUCE A | Director | Option Exercise | A | 0.91 | 30,000 | 27,300 | 30,000 | |
| Jun 19 2019 | BIOC | BIOCEPT INC | Chandler Marsha Alpert | Director | Option Exercise | A | 1.02 | 500 | 510 | 500 | |
| Jun 19 2019 | BIOC | BIOCEPT INC | Chandler Marsha Alpert | Director | Option Exercise | A | 0.91 | 30,000 | 27,300 | 30,000 | |
| Jun 19 2019 | BIOC | BIOCEPT INC | ARNOLD LYLE J | SR VP of R&D and CS ... | Option Exercise | A | 0.91 | 175,000 | 159,250 | 175,000 | |
| Jun 19 2019 | BIOC | BIOCEPT INC | Hendrick Edwin | SVP, Chief Commerci ... | Option Exercise | A | 0.91 | 160,000 | 145,600 | 160,000 | |
| Jun 19 2019 | BIOC | BIOCEPT INC | TERRY MICHAEL J | Sr VP Comm. Operati ... | Option Exercise | A | 0.91 | 90,000 | 81,900 | 90,000 | |
| Oct 02 2018 | BIOC | BIOCEPT INC | Hendrick Edwin | SVP, Chief Commerci ... | Option Exercise | A | 2.75 | 45,000 | 123,750 | 45,000 | |
| Jul 02 2018 | BIOC | BIOCEPT INC | Wilson Margaret Faye | Director | Option Exercise | A | 0.20 | 15,000 | 3,000 | 15,000 | |
| Jul 02 2018 | BIOC | BIOCEPT INC | ROYSTON IVOR | Director | Option Exercise | A | 0.20 | 15,000 | 3,000 | 15,000 | |
| Jul 02 2018 | BIOC | BIOCEPT INC | HUEBNER BRUCE A | Director | Option Exercise | A | 0.20 | 15,000 | 3,000 | 15,000 | |
| Jul 02 2018 | BIOC | BIOCEPT INC | Gerhardt Bruce | Director | Option Exercise | A | 0.20 | 15,000 | 3,000 | 15,000 | |
| Jul 02 2018 | BIOC | BIOCEPT INC | Chandler Marsha Alpert | Director | Option Exercise | A | 0.20 | 15,000 | 3,000 | 15,000 | |
| Jun 06 2018 | BIOC | BIOCEPT INC | Gerhardt Bruce | Director | Option Exercise | P | 0.50 | 25,000 | 12,500 | 25,000 | |
| Jun 06 2018 | BIOC | BIOCEPT INC | Gerhardt Bruce | Director | Buy | P | 0.00 | 25,000 | 0 | 98,303 | 73.3 K to 98.3 K (+34.11 %) |
| Jun 02 2017 | BIOC | BIOCEPT INC | Wilson Margaret Faye | Director | Option Exercise | A | 1.50 | 15,000 | 22,500 | 15,000 | |
| Jun 02 2017 | BIOC | BIOCEPT INC | ROYSTON IVOR | Director | Option Exercise | A | 1.50 | 15,000 | 22,500 | 15,000 | |
| Jun 02 2017 | BIOC | BIOCEPT INC | HUEBNER BRUCE A | Director | Option Exercise | A | 1.50 | 15,000 | 22,500 | 15,000 | |
| Jun 02 2017 | BIOC | BIOCEPT INC | HALE DAVID F | Director | Option Exercise | A | 1.50 | 15,000 | 22,500 | 15,000 | |
| Jun 02 2017 | BIOC | BIOCEPT INC | Singh Veena | Sr VP & Sr Med Dire ... | Option Exercise | A | 1.50 | 50,000 | 75,000 | 50,000 | |
| Jun 02 2017 | BIOC | BIOCEPT INC | Singh Veena | Sr VP & Sr Med Dire ... | Grant | A | 0.00 | 25,000 | 0 | 51,666 | 26.7 K to 51.7 K (+93.75 %) |
| Jun 02 2017 | BIOC | BIOCEPT INC | ARNOLD LYLE J | SR VP of R&D and CS ... | Option Exercise | A | 1.50 | 75,000 | 112,500 | 75,000 | |
| Jun 02 2017 | BIOC | BIOCEPT INC | ARNOLD LYLE J | SR VP of R&D and CS ... | Grant | A | 0.00 | 25,000 | 0 | 90,238 | 65.2 K to 90.2 K (+38.32 %) |
| Apr 03 2017 | BIOC | BIOCEPT INC | Wilson Margaret Faye | Director | Option Exercise | A | 2.13 | 4,166 | 8,874 | 4,166 | |
| Apr 03 2017 | BIOC | BIOCEPT INC | Neff Edward A. | Director | Option Exercise | A | 2.13 | 4,166 | 8,874 | 4,166 | |
| Apr 03 2017 | BIOC | BIOCEPT INC | Gerhardt Bruce | Director | Option Exercise | A | 2.13 | 4,166 | 8,874 | 4,166 | |
| Apr 03 2017 | BIOC | BIOCEPT INC | ROYSTON IVOR | Director | Option Exercise | A | 2.13 | 4,166 | 8,874 | 4,166 | |
| Apr 03 2017 | BIOC | BIOCEPT INC | HALE DAVID F | Director | Option Exercise | A | 2.13 | 4,166 | 8,874 | 4,166 | |
| Apr 03 2017 | BIOC | BIOCEPT INC | Chandler Marsha Alpert | Director | Option Exercise | A | 2.13 | 4,166 | 8,874 | 4,166 | |
| Apr 03 2017 | BIOC | BIOCEPT INC | HUEBNER BRUCE A | Director | Option Exercise | A | 2.13 | 4,166 | 8,874 | 4,166 | |
| Mar 29 2017 | BIOC | BIOCEPT INC | ROYSTON IVOR | Director | Buy | P | 8.76 | 5,667 | 49,643 | 17,294 | 11.6 K to 17.3 K (+48.74 %) |
| Mar 22 2017 | BIOC | BIOCEPT INC | Kennedy Timothy | CFO, Sr V.P. Operat ... | Option Exercise | A | 1.95 | 16,383 | 31,947 | 16,383 | |
| Mar 22 2017 | BIOC | BIOCEPT INC | Nall Michael W. | CEO & President | Option Exercise | A | 4.02 | 10,000 | 40,200 | 10,000 | |
| Mar 22 2017 | BIOC | BIOCEPT INC | Nall Michael W. | CEO & President | Option Exercise | A | 6.03 | 6,333 | 38,188 | 6,333 | |
| Feb 28 2017 | BIOC | BIOCEPT INC | TERRY MICHAEL J | Sr VP Comm. Operati ... | Option Exercise | A | 2.05 | 50,000 | 102,500 | 50,000 | |
| Jan 26 2017 | BIOC | BIOCEPT INC | Ally Bridge LB Healthcare Mast ... | 10% Owner | Sell | D | 1.10 | 254,893 | 280,382 | 0 | 254.9 K to 0 (-100.00 %) |
| Jan 26 2017 | BIOC | BIOCEPT INC | Ally Bridge LB Healthcare Mast ... | 10% Owner | Sell | D | 1.10 | 549,708 | 604,679 | 254,893 | 804.6 K to 254.9 K (-68.32 %) |
| Jan 26 2017 | BIOC | BIOCEPT INC | Ally Bridge LB Healthcare Mast ... | 10% Owner | Sell | D | 1.10 | 876,399 | 964,039 | 804,601 | 1.7 M to 804.6 K (-52.14 %) |
| Oct 21 2016 | BIOC | BIOCEPT INC | Nall Michael W. | CEO & President | Option Exercise | P | 1.10 | 36,363 | 39,999 | 36,363 | |
| Oct 21 2016 | BIOC | BIOCEPT INC | Nall Michael W. | CEO & President | Buy | P | 1.10 | 36,363 | 39,999 | 49,575 | 13.2 K to 49.6 K (+275.23 %) |
| Oct 21 2016 | BIOC | BIOCEPT INC | Nall Michael W. | CEO & President | Gift | G | 0.00 | 4,450 | 0 | 13,212 | 8.8 K to 13.2 K (+50.79 %) |
| Oct 21 2016 | BIOC | BIOCEPT INC | Nall Michael W. | CEO & President | Gift | G | 0.00 | 4,450 | 0 | 25,000 | 29.5 K to 25 K (-15.11 %) |
| Oct 21 2016 | BIOC | BIOCEPT INC | Nall Michael W. | CEO & President | Gift | G | 0.00 | 4,762 | 0 | 8,762 | 4 K to 8.8 K (+119.05 %) |
| Oct 21 2016 | BIOC | BIOCEPT INC | Nall Michael W. | CEO & President | Gift | G | 0.00 | 4,762 | 0 | 29,450 | 34.2 K to 29.5 K (-13.92 %) |
| Oct 21 2016 | BIOC | BIOCEPT INC | Nall Michael W. | CEO & President | Gift | G | 0.00 | 4,000 | 0 | 4,000 | 0 to 4 K |
| Oct 21 2016 | BIOC | BIOCEPT INC | Nall Michael W. | CEO & President | Gift | G | 0.00 | 4,000 | 0 | 34,212 | 38.2 K to 34.2 K (-10.47 %) |
| Oct 21 2016 | BIOC | BIOCEPT INC | Chandler Marsha Alpert | Director | Option Exercise | P | 1.10 | 4,545 | 5,000 | 4,545 | |
| Oct 21 2016 | BIOC | BIOCEPT INC | Chandler Marsha Alpert | Director | Buy | P | 1.10 | 4,545 | 5,000 | 5,212 | 667 to 5.2 K (+681.41 %) |
| Oct 21 2016 | BIOC | BIOCEPT INC | Chandler Marsha Alpert | Director | Gift | G | 0.00 | 1,693 | 0 | 1,693 | 0 to 1.7 K |
| Oct 21 2016 | BIOC | BIOCEPT INC | Chandler Marsha Alpert | Director | Gift | G | 0.00 | 1,693 | 0 | 667 | 2.4 K to 667 (-71.74 %) |
| Oct 21 2016 | BIOC | BIOCEPT INC | Kennedy Timothy | CFO, Sr V.P. Operat ... | Option Exercise | P | 1.10 | 36,363 | 39,999 | 36,363 | |
| Oct 21 2016 | BIOC | BIOCEPT INC | Kennedy Timothy | CFO, Sr V.P. Operat ... | Buy | P | 1.10 | 36,363 | 39,999 | 61,363 | 25 K to 61.4 K (+145.45 %) |
| Oct 21 2016 | BIOC | BIOCEPT INC | HUEBNER BRUCE A | Director | Option Exercise | P | 1.10 | 20,000 | 22,000 | 20,000 | |
| Oct 21 2016 | BIOC | BIOCEPT INC | HUEBNER BRUCE A | Director | Buy | P | 1.10 | 20,000 | 22,000 | 24,000 | 4 K to 24 K (+500.00 %) |
| Oct 21 2016 | BIOC | BIOCEPT INC | Gerhardt Bruce | Director | Option Exercise | P | 1.10 | 50,000 | 55,000 | 50,000 | |
| Oct 21 2016 | BIOC | BIOCEPT INC | Gerhardt Bruce | Director | Buy | P | 1.10 | 50,000 | 55,000 | 73,304 | 23.3 K to 73.3 K (+214.56 %) |
| Oct 21 2016 | BIOC | BIOCEPT INC | Singh Veena | Sr VP & Sr Med Dire ... | Option Exercise | P | 1.10 | 10,000 | 11,000 | 10,000 | |
| Oct 21 2016 | BIOC | BIOCEPT INC | Singh Veena | Sr VP & Sr Med Dire ... | Buy | P | 1.10 | 10,000 | 11,000 | 26,666 | 16.7 K to 26.7 K (+60.00 %) |
| Oct 21 2016 | BIOC | BIOCEPT INC | ARNOLD LYLE J | SR VP of R&D and CS ... | Option Exercise | P | 1.10 | 45,000 | 49,500 | 45,000 | |
| Oct 21 2016 | BIOC | BIOCEPT INC | ARNOLD LYLE J | SR VP of R&D and CS ... | Buy | P | 1.10 | 45,000 | 49,500 | 65,238 | 20.2 K to 65.2 K (+222.35 %) |
| Oct 21 2016 | BIOC | BIOCEPT INC | Wilson Margaret Faye | Director | Option Exercise | P | 1.10 | 13,636 | 15,000 | 13,636 | |
| Oct 21 2016 | BIOC | BIOCEPT INC | Wilson Margaret Faye | Director | Buy | P | 1.10 | 13,636 | 15,000 | 25,067 | 11.4 K to 25.1 K (+119.29 %) |
| Oct 21 2016 | BIOC | BIOCEPT INC | Reiss Claire | 10% Owner | Option Exercise | P | 1.10 | 227,272 | 249,999 | 227,272 | |
| Oct 21 2016 | BIOC | BIOCEPT INC | Reiss Claire | 10% Owner | Buy | P | 1.10 | 227,272 | 249,999 | 1,046,613 | 819.3 K to 1 M (+27.74 %) |
| Oct 21 2016 | BIOC | BIOCEPT INC | Neff Edward A. | Director | Option Exercise | P | 1.10 | 227,272 | 249,999 | 227,272 | |
| Oct 21 2016 | BIOC | BIOCEPT INC | Neff Edward A. | Director | Buy | P | 1.10 | 227,272 | 249,999 | 289,735 | 62.5 K to 289.7 K (+363.85 %) |
| Oct 21 2016 | BIOC | BIOCEPT INC | HALE DAVID F | Director | Option Exercise | P | 1.10 | 90,909 | 100,000 | 90,909 | |
| Oct 21 2016 | BIOC | BIOCEPT INC | HALE DAVID F | Director | Buy | P | 1.10 | 90,909 | 100,000 | 109,099 | 18.2 K to 109.1 K (+499.77 %) |
| Oct 21 2016 | BIOC | BIOCEPT INC | HALE DAVID F | Director | Gift | G | 0.00 | 13,334 | 0 | 16,736 | 3.4 K to 16.7 K (+391.95 %) |
| Oct 21 2016 | BIOC | BIOCEPT INC | HALE DAVID F | Director | Gift | G | 0.00 | 13,334 | 0 | 18,190 | 31.5 K to 18.2 K (-42.30 %) |
| Aug 01 2016 | BIOC | BIOCEPT INC | Kennedy Timothy | CFO, Sr V.P. Operat ... | Option Exercise | A | 0.65 | 200,000 | 130,000 | 200,000 | |
| Aug 01 2016 | BIOC | BIOCEPT INC | Kennedy Timothy | CFO, Sr V.P. Operat ... | Grant | A | 0.00 | 75,000 | 0 | 75,000 | 0 to 75 K |
| Jul 07 2016 | BIOC | BIOCEPT INC | ARNOLD LYLE J | SR VP of R&D and CS ... | Grant | A | 0.00 | 50,000 | 0 | 60,714 | 10.7 K to 60.7 K (+466.68 %) |
| Jul 07 2016 | BIOC | BIOCEPT INC | Singh Veena | Sr VP & Sr Med Dire ... | Grant | A | 0.00 | 50,000 | 0 | 50,000 | 0 to 50 K |
| Jul 07 2016 | BIOC | BIOCEPT INC | Nall Michael W. | CEO & President | Grant | A | 0.00 | 75,000 | 0 | 114,634 | 39.6 K to 114.6 K (+189.23 %) |
| May 05 2016 | BIOC | BIOCEPT INC | HALE DAVID F | Director | Option Exercise | P | 1.30 | 35,000 | 45,500 | 35,000 | |
| May 05 2016 | BIOC | BIOCEPT INC | HALE DAVID F | Director | Buy | P | 1.00 | 50,000 | 50,000 | 138,356 | 88.4 K to 138.4 K (+56.59 %) |
| May 05 2016 | BIOC | BIOCEPT INC | Neff Edward A. | Director | Option Exercise | P | 1.30 | 70,000 | 91,000 | 70,000 | |
| May 05 2016 | BIOC | BIOCEPT INC | Neff Edward A. | Director | Buy | P | 1.00 | 100,000 | 100,000 | 112,913 | 12.9 K to 112.9 K (+774.41 %) |
| May 05 2016 | BIOC | BIOCEPT INC | Gerhardt Bruce | Director | Option Exercise | P | 1.30 | 17,500 | 22,750 | 17,500 | |
| May 05 2016 | BIOC | BIOCEPT INC | Gerhardt Bruce | Director | Buy | P | 1.00 | 25,000 | 25,000 | 58,985 | 34 K to 59 K (+73.56 %) |
| May 05 2016 | BIOC | BIOCEPT INC | Reiss Claire | 10% Owner | Option Exercise | P | 1.30 | 429,991 | 558,988 | 429,991 | |
| May 05 2016 | BIOC | BIOCEPT INC | Reiss Claire | 10% Owner | Buy | P | 1.00 | 614,273 | 614,273 | 2,458,016 | 1.8 M to 2.5 M (+33.32 %) |
| Mar 01 2016 | BIOC | BIOCEPT INC | Trivedi Raaj | VP Commercial Opera ... | Option Exercise | A | 1.34 | 17,500 | 23,450 | 17,500 | |
| Mar 01 2016 | BIOC | BIOCEPT INC | Singh Veena | Sr VP & Sr Med Dire ... | Option Exercise | A | 1.34 | 50,000 | 67,000 | 50,000 | |
| Mar 01 2016 | BIOC | BIOCEPT INC | Nall Michael W. | CEO & President | Option Exercise | A | 1.34 | 50,000 | 67,000 | 50,000 | |
| Mar 01 2016 | BIOC | BIOCEPT INC | Nall Michael W. | CEO & President | Grant | A | 0.00 | 13,348 | 0 | 39,634 | 26.3 K to 39.6 K (+50.78 %) |
| Mar 01 2016 | BIOC | BIOCEPT INC | ARNOLD LYLE J | SR VP of R&D and CS ... | Option Exercise | A | 1.34 | 25,000 | 33,500 | 25,000 | |
| Jan 04 2016 | BIOC | BIOCEPT INC | Wilson Margaret Faye | Director | Option Exercise | A | 1.38 | 12,500 | 17,250 | 12,500 | |
| Jan 04 2016 | BIOC | BIOCEPT INC | ROYSTON IVOR | Director | Option Exercise | A | 1.38 | 12,500 | 17,250 | 12,500 | |
| Jan 04 2016 | BIOC | BIOCEPT INC | Neff Edward A. | Director | Option Exercise | A | 1.38 | 12,500 | 17,250 | 12,500 | |
| Jan 04 2016 | BIOC | BIOCEPT INC | HUEBNER BRUCE A | Director | Option Exercise | A | 1.38 | 12,500 | 17,250 | 12,500 | |
| Jan 04 2016 | BIOC | BIOCEPT INC | Gerhardt Bruce | Director | Option Exercise | A | 1.38 | 12,500 | 17,250 | 12,500 | |
| Jan 04 2016 | BIOC | BIOCEPT INC | Chandler Marsha Alpert | Director | Option Exercise | A | 1.38 | 12,500 | 17,250 | 12,500 | |
| Jan 04 2016 | BIOC | BIOCEPT INC | HALE DAVID F | Director | Option Exercise | A | 1.38 | 12,500 | 17,250 | 12,500 | |
| Nov 10 2015 | BIOC | BIOCEPT INC | ROYSTON IVOR | Director | Option Exercise | M | 0.00 | 9,285 | 0 | 0 | |
| Nov 10 2015 | BIOC | BIOCEPT INC | ROYSTON IVOR | Director | Buy | M | 0.00 | 9,285 | 0 | 34,878 | 25.6 K to 34.9 K (+36.28 %) |
| Nov 10 2015 | BIOC | BIOCEPT INC | HALE DAVID F | Chairman | Option Exercise | M | 0.00 | 53,662 | 0 | 0 | |
| Nov 10 2015 | BIOC | BIOCEPT INC | HALE DAVID F | Chairman | Option Exercise | M | 0.00 | 10,204 | 0 | 0 | |
| Nov 10 2015 | BIOC | BIOCEPT INC | HALE DAVID F | Chairman | Buy | M | 0.00 | 53,662 | 0 | 88,356 | 34.7 K to 88.4 K (+154.67 %) |
| Nov 10 2015 | BIOC | BIOCEPT INC | HALE DAVID F | Chairman | Buy | M | 0.00 | 10,204 | 0 | 34,694 | 24.5 K to 34.7 K (+41.67 %) |
| Sep 02 2015 | BIOC | BIOCEPT INC | Singh Veena | Sr VP & Sr Med Dire ... | Option Exercise | A | 2.01 | 175,000 | 351,750 | 175,000 | |
| Sep 02 2015 | BIOC | BIOCEPT INC | Trivedi Raaj | VP Commercial Opera ... | Option Exercise | A | 2.01 | 47,000 | 94,470 | 47,000 | |
| Sep 02 2015 | BIOC | BIOCEPT INC | Nall Michael W. | CEO & President | Option Exercise | A | 2.01 | 150,000 | 301,500 | 150,000 | |
| Sep 02 2015 | BIOC | BIOCEPT INC | FOLETTA MARK G | Interim CFO | Option Exercise | A | 2.01 | 50,000 | 100,500 | 50,000 | |
| Sep 02 2015 | BIOC | BIOCEPT INC | ARNOLD LYLE J | SR VP of R&D and CS ... | Option Exercise | A | 2.01 | 175,000 | 351,750 | 175,000 | |
| Aug 25 2015 | BIOC | BIOCEPT INC | Nall Michael W. | CEO & President | Option Exercise | M | 0.00 | 14,286 | 0 | 0 | |
| Aug 25 2015 | BIOC | BIOCEPT INC | Nall Michael W. | CEO & President | Buy | M | 0.00 | 14,286 | 0 | 26,286 | 12 K to 26.3 K (+119.05 %) |
| Aug 25 2015 | BIOC | BIOCEPT INC | HALE DAVID F | Chairman | Option Exercise | M | 0.00 | 14,286 | 0 | 0 | |
| Aug 25 2015 | BIOC | BIOCEPT INC | HALE DAVID F | Chairman | Buy | M | 0.00 | 14,286 | 0 | 24,490 | 10.2 K to 24.5 K (+140.00 %) |
| Aug 25 2015 | BIOC | BIOCEPT INC | ARNOLD LYLE J | SR VP of R&D and CS ... | Option Exercise | M | 0.00 | 10,714 | 0 | 0 | |
| Aug 25 2015 | BIOC | BIOCEPT INC | ARNOLD LYLE J | SR VP of R&D and CS ... | Buy | M | 0.00 | 10,714 | 0 | 10,714 | 0 to 10.7 K |
| Jul 08 2015 | BIOC | BIOCEPT INC | Gerhardt Bruce | Director | Option Exercise | M | 0.00 | 8,735 | 0 | 0 | |
| Jul 08 2015 | BIOC | BIOCEPT INC | Gerhardt Bruce | Director | Buy | M | 0.00 | 8,735 | 0 | 33,985 | 25.3 K to 34 K (+34.59 %) |
| Jul 08 2015 | BIOC | BIOCEPT INC | Wilson Margaret Faye | Director | Option Exercise | M | 0.00 | 14,285 | 0 | 0 | |
| Jul 08 2015 | BIOC | BIOCEPT INC | Wilson Margaret Faye | Director | Buy | M | 0.00 | 14,285 | 0 | 23,359 | 9.1 K to 23.4 K (+157.43 %) |
| Jul 08 2015 | BIOC | BIOCEPT INC | ROYSTON IVOR | Director | Option Exercise | M | 0.00 | 8,735 | 0 | 0 | |
| Jul 08 2015 | BIOC | BIOCEPT INC | ROYSTON IVOR | Director | Buy | M | 0.00 | 8,735 | 0 | 25,593 | 16.9 K to 25.6 K (+51.82 %) |
| Jul 08 2015 | BIOC | BIOCEPT INC | Neff Edward A. | Director | Option Exercise | M | 0.00 | 8,735 | 0 | 0 |